Rezultati - Michal Bar‐Natan

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia

    Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia od Guido Lancman, John Mascarenhas, Michal Bar‐Natan

    Izdano 2020
    Polni tekst Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    STAT signaling in the pathogenesis and treatment of myeloid malignancies

    STAT signaling in the pathogenesis and treatment of myeloid malignancies od Michal Bar‐Natan, Erik A. Nelson, Michael Xiang, David A. Frank

    Izdano 2012
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors

    The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors od Erik A. Nelson, Sarah R. Walker, Ellen Weisberg, Michal Bar‐Natan, Rosemary Barrett, Laurie Gashin, Shariya Terrell, Josephine L. Klitgaard, Loredana Santo, Martha R. Addorio, Benjamin L. Ebert, James D. Griffin, David A. Frank

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations

    The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations od E Andrea Nelson, Sue Walker, Michael Xiang, Ellen Weisberg, Michal Bar‐Natan, R J Barrett, S. Liu, Surender Kharbanda, Amanda L. Christie, Maria Nicolais, James D. Griffin, Richard M. Stone, Andrew L. Kung, David A. Frank

    Izdano 2012
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies

    Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies od Jonathan Feld, Douglas Tremblay, Mikaela Dougherty, Tina Czaplinska, Gillian Sanchez, Claudia Brady, Marina Kremyanskaya, Michal Bar‐Natan, Alla Keyzner, Bridget K. Marcellino, Janice Gabrilove, Shyamala C. Navada, Lewis R. Silverman, Siraj M. El Jamal, John Mascarenhas, Alan H. Shih

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

    TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients od Rafael Bejar, Allegra M. Lord, Kristen E. Stevenson, Michal Bar‐Natan, Albert Pérez-Ladaga, Jacques Zaneveld, Hui Wang, Bennett Adam Caughey, Petar Stojanov, Gad Getz, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Rui Chen, Richard M. Stone, Donna Neuberg, David P. Steensma, Benjamin L. Ebert

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures

    Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures od Alberto Herrera, Anthony Cheng, Eleni P. Mimitou, Angelina Seffens, Dean David George, Michal Bar‐Natan, Adriana Heguy, Kelly V. Ruggles, Jose U. Scher, Kenneth B. Hymes, Jo‐Ann Latkowski, Niels Ødum, Marshall E. Kadin, Zhengqing Ouyang, Larisa J. Geskin, Peter Smibert, Terkild B. Buus, Sergei B. Koralov

    Izdano 2021
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets

    A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets od Sophia Adamia, Benjamin Haibe‐Kains, Patrick M. Pilarski, Michal Bar‐Natan, Samuel Pevzner, Hervé Avet‐Loiseau, Laurence Lodé, Sigitas Verselis, Edward A. Fox, John P. Burke, Ilene Galinsky, Ibiayi Dagogo‐Jack, Martha Wadleigh, David P. Steensma, Gabriela Motyckova, Daniel J. DeAngelo, John Quackenbush, Richard M. Stone, James D. Griffin

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent

    Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent od Michael Xiang, Haesook Kim, Vincent T. Ho, Sarah R. Walker, Michal Bar‐Natan, Melodi Anahtar, Suhu Liu, Patricia A. Toniolo, Yasmin Kroll, Nichole Jones, Zachary T. Giaccone, Lisa N. Heppler, Darwin Q. Ye, Jason Marineau, Daniel L. Shaw, James E. Bradner, Traci M. Blonquist, Donna Neuberg, Claudio Hetz, Richard M. Stone, Robert J. Soiffer, David A. Frank

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML

    NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML od Sophia Adamia, Michal Bar‐Natan, Benjamin Haibe‐Kains, Patrick M. Pilarski, Christian Bach, Samuel Pevzner, Teresa Calimeri, Hervé Avet‐Loiseau, Laurence Lodé, Sigitas Verselis, Edward A. Fox, Ilene Galinsky, Steven N. Mathews, Ibiayi Dagogo‐Jack, Martha Wadleigh, David P. Steensma, Gabriela Motyckova, Daniel J. DeAngelo, John Quackenbush, Daniel G. Tenen, Richard M. Stone, James D. Griffin

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia

    Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia od Akinori Yoda, Yuka Yoda, Sabina Chiaretti, Michal Bar‐Natan, Kartik Mani, Scott J. Rodig, Nathan West, Yun Xiao, Jennifer R. Brown, Constantine S. Mitsiades, Martin Sattler, Jeffrey L. Kutok, Daniel J. DeAngelo, Martha Wadleigh, Alfonso Piciocchi, Paola Dal Cin, James E. Bradner, James D. Griffin, Kenneth C. Anderson, Richard M. Stone, Jerome Ritz, Robin Foà, Jon C. Aster, David A. Frank, David M. Weinstock

    Izdano 2009
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs

    MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs od Athalia R. Pyzer, Dina Stroopinsky, Jacalyn Rosenblatt, Eleni Anastasiadou, Hasan Rajabi, Abigail Washington, Ashujit Tagde, JH Chu, Maxwell Coll, A L Jiao, Linus Tsai, D E Tenen, L. J. Cole, Kenneth C. Palmer, A. Ephraim, Rebecca Karp Leaf, Michelle Nahas, A Apel, Michal Bar‐Natan, Salvia Jain, Malgorzata McMasters, Laura Méndez, John T. Arnason, Benjamin A. Raby, Frank J. Slack, D Kufe, David Avigan

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

    TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups od Detlef Haase, Kristen E. Stevenson, Donna Neuberg, Jaroslaw P. Maciejewski, Aziz Nazha, Mikkael A. Sekeres, Benjamin L. Ebert, Guillermo Garcia‐Manero, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern, Seishi Ogawa, Yasunobu Nagata, Kenichi Yoshida, Timothy A. Graubert, Matthew J. Walter, Alan F. List, Rami S. Komrokji, Eric Padron, David A. Sallman, Elli Papaemmanuil, Peter J. Campbell, Michael R. Savona, Adam C. Seegmiller, Lionel Adès, Pierre Fenaux, Lee‐Yung Shih, David Bowen, Michael J. Groves, Sudhir Tauro, Michaëla Fontenay, Olivier Kosmider, Michal Bar‐Natan, David P. Steensma, Richard M. Stone, Michael Heuser, Felicitas Thol, Mario Cazzola, Luca Malcovati, Aly Karsan, Christina Ganster, Eva Hellström‐Lindberg, Jacqueline Boultwood, Andrea Pellagatti, Valeria Santini, Lynn Quek, Paresh Vyas, Heinz Tüchler, Peter L. Greenberg, Rafael Bejar

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

    Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts od Amer M. Zeidan, Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal, Rory M. Shallis, David P. Steensma, Michael R. Savona, Mikkael A. Sekeres, Gail J. Roboz, Daniel J. DeAngelo, Andre C. Schuh, Eric Padron, Joshua F. Zeidner, Roland B. Walter, Francesco Onida, Amir T. Fathi, Amy E. DeZern, Gabriela S. Hobbs, Eytan M. Stein, Paresh Vyas, Andrew H. Wei, David Bowen, Pau Montesinos, Elizabeth A. Griffiths, Amit Verma, Alla Keyzner, Michal Bar‐Natan, Shyamala C. Navada, Marina Kremyanskaya, Aaron D. Goldberg, Aref Al‐Kali, Mark Heaney, Aziz Nazha, Huda Salman, Selina M. Luger, Keith W. Pratz, Helmut König, Rami S. Komrokji, Michael W. Deininger, Blanca Xicoy Cirici, Vijaya Raj Bhatt, Lewis R. Silverman, Harry P. Erba, Pierre Fenaux, Uwe Platzbecker, Valeria Santini, Eunice S. Wang, Martin S. Tallman, Richard M. Stone, John Mascarenhas

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: